FPH — Fisher & Paykel Healthcare Share Price
0.000.00%
Last trade - 00:00- NZ$19.11bn
- NZ$19.14bn
- NZ$1.74bn
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 45.08 | ||
| PEG Ratio (f) | 2.79 | ||
| EPS Growth (f) | 19.28% | ||
| Dividend Yield (f) | 1.59% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 9.9 | ||
| Price to Tang. Book | 10.35 | ||
| Price to Free Cashflow | 49.31 | ||
| Price to Sales | 10.11 | ||
| EV to EBITDA | 42.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 15.55% | ||
| Return on Equity | 9.7% | ||
| Operating Margin | 16.97% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | NZ$m | 1,263.7 | 1,971.2 | 1,681.7 | 1,581.1 | 1,742.8 | 2,007.43 | 2,277.37 | 10.24% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +26.9 | +82.29 | -28.15 | -33.78 | -25.56 | +90.72 | +18.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Fisher & Paykel Healthcare Corporation Limited designs, manufactures and markets products and systems for use in acute and chronic respiratory care, surgery, and the treatment of obstructive sleep apnea. The Company provides medical device products and systems for use in both hospital and homecare settings. Its hospital product group includes products used in invasive ventilation, noninvasive ventilation, nasal high flow therapy, anesthesia, and laparoscopic and open surgery. Its homecare product group includes devices and systems used to treat obstructive sleep apnea (OSA) and provide respiratory support in the home, which include its continuous positive airway pressure (CPAP) therapy masks as well as flow generators, interfaces, and data management technologies. The Company’s products are sold in over 120 countries worldwide. It operates across Canada, the United States of America, Mexico, Costa Rica, the United Kingdom, Switzerland, India, and others.
Directors
- Scott St. John NEC
- Lewis Gradon CEO
- Lyndal York CFO
- Paul Shearer SVP
- Nicola Talbot VPR
- Marcus Driller VPR
- Winston Fong VPR
- Nicholas Fourie VPR
- Brian Schultz VPR
- Andrew Robert Somervell VPR
- Jonti Rhodes GMG
- Michael Daniell NED (65)
- Philippa Mary Greenwood NID
- Geraldine McBride NID (60)
- Lisa Mcintyre NID
- Neville Mitchell NID (62)
- Donal O'Dwyer NID (68)
- Last Annual
- March 31st, 2024
- Last Interim
- September 30th, 2024
- Incorporated
- July 27th, 1954
- Public Since
- November 13th, 2001
- No. of Shareholders
- 26,247
- No. of Employees
- 7,141
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- New Zealand Stock Exchange
- Shares in Issue
- 586,112,745
- Address
- 15 Maurice Paykel Place, East Tamaki,, AUCKLAND, 2013
- Web
- https://www.fphcare.com/
- Phone
- +64 95740100
- Auditors
- Toitu Envirocare
Upcoming Events for FPH
Fisher & Paykel Healthcare Corporation Ltd Investor Day
Fisher & Paykel Healthcare Corporation Ltd Annual Shareholders Meeting
Similar to FPH
Truscreen
New Zealand Stock Exchange
FAQ
What is the Fisher & Paykel Healthcare share price?
As of Today at 19:39 UTC, shares in Fisher & Paykel Healthcare are trading at NZ$32.60. This share price information is delayed by 15 minutes.
How has the Fisher & Paykel Healthcare share price performed this year?
Shares in Fisher & Paykel Healthcare last closed at NZ$32.60 and the price had moved by +25.19% over the past 365 days. In terms of relative price strength the Fisher & Paykel Healthcare share price has outperformed the ASX All Ordinaries Index by +23.87% over the past year.
What are the analyst and broker recommendations for Fisher & Paykel Healthcare?
The overall consensus recommendation for Fisher & Paykel Healthcare is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Fisher & Paykel Healthcare dividend yield?
The Fisher & Paykel Healthcare dividend yield is 1.29% based on the trailing twelve month period.
Does Fisher & Paykel Healthcare pay a dividend?
Last year, Fisher & Paykel Healthcare paid a total dividend of NZ$0.42, and it currently has a trailing dividend yield of 1.29%. We do not have any data on when Fisher & Paykel Healthcare is to next pay dividends.
When does Fisher & Paykel Healthcare next pay dividends?
We do not have data on when Fisher & Paykel Healthcare is to next pay dividends. The historic dividend yield on Fisher & Paykel Healthcare shares is currently 1.29%.
How do I buy Fisher & Paykel Healthcare shares?
To buy shares in Fisher & Paykel Healthcare you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Fisher & Paykel Healthcare?
As of the previous close price of NZ$32.60, shares in Fisher & Paykel Healthcare had a market capitalisation of NZ$19.11bn.
Where are Fisher & Paykel Healthcare shares listed?
Here are the trading details for Fisher & Paykel Healthcare:
- Country of listing: New Zealand
- Exchange: NZC
- Ticker Symbol: FPH
What kind of share is Fisher & Paykel Healthcare?
Based on an overall assessment of its quality, value and momentum Fisher & Paykel Healthcare is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Fisher & Paykel Healthcare share price forecast for 2025?
The analyst consensus target price for shares in Fisher & Paykel Healthcare is NZ$35.43. That is 8.68% above the last closing price of NZ$32.60.
Analysts covering Fisher & Paykel Healthcare currently have a consensus Earnings Per Share (EPS) forecast of NZ$0.61 for the next financial year.
Find out moreWhat is the trend in the Fisher & Paykel Healthcare share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fisher & Paykel Healthcare. Over the past six months, its share price has underperformed the ASX All Ordinaries Index by -3.99%.
As of the last closing price of NZ$32.60, shares in Fisher & Paykel Healthcare were trading -7.24% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Fisher & Paykel Healthcare PE Ratio?
The Fisher & Paykel Healthcare PE ratio based on its reported earnings over the past 12 months is 45.08. The shares last closed at NZ$32.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Fisher & Paykel Healthcare?
Fisher & Paykel Healthcare's management team is headed by:
- Scott St. John - NEC
- Lewis Gradon - CEO
- Lyndal York - CFO
- Paul Shearer - SVP
- Nicola Talbot - VPR
- Marcus Driller - VPR
- Winston Fong - VPR
- Nicholas Fourie - VPR
- Brian Schultz - VPR
- Andrew Robert Somervell - VPR
- Jonti Rhodes - GMG
- Michael Daniell - NED
- Philippa Mary Greenwood - NID
- Geraldine McBride - NID
- Lisa Mcintyre - NID
- Neville Mitchell - NID
- Donal O'Dwyer - NID